Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CXCL10 |
| Upstream (Parents) |
|---|
| (<<) IDO1 → CXCL10 |
| (<<) GBP1 → CXCL10 |
| (<<) CD2 → CXCL10 |
| (<<) CD74 → CXCL10 |
| (<<) CCL5 → CXCL10 |
| (<<) CXCL9 → CXCL10 |
| Downstream (Children) |
|---|
| CXCL10 → IDO1 (>>) |
| CXCL10 → HOXB1 (>>) |
| CXCL10 → POU3F3 (>>) |
| CXCL10 → MATN4 (>>) |
| CXCL10 → ALX4 (>>) |
| CXCL10 → ICOS (>>) |
| CXCL10 → MYL7 (>>) |
| CXCL10 → PSMB9 (>>) |
| CXCL10 → TAP1 (>>) |
| CXCL10 → CXCL11 (>>) |
| CXCL10 → CXCL9 (>>) |
